Clinical Trials

Clinical Trials

There are 7 trials:
Facility: rapid city regional hospital

NCT	Trial Name	# of Centers
NCT00892177	Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme	308
NCT02152982	Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme	273
NCT01648348	Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme	242
NCT00869401	Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme	207
NCT00978458	Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma	168
NCT00887146	Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma	158
NCT00329719	Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma	121